Fundraising Fox

Bloomsurgical

Founded 2021 · 14 employees on LinkedIn · 1 known investors

Bloom Surgical develops an origami-inspired, single-use laparoscope cleaning attachment that cleans the scope lens inside the abdomen without removing it, using a wiper and irrigation to remove fog, blood, and cautery debris. The device is designed for minimally invasive surgery and fits any 5 or 10 mm scope through leading trocars.

Also known as Bloom Surgical · Bloom Surgical, Inc. · LaparoVision

Investors · 1

Company profile

researched Aug 2026

Bloom Surgical, Inc. is a Utah-based surgical device startup developing an origami-inspired laparoscope cleaning attachment, marketed under the LaparoVision name as a scope wiper and irrigation cleaning system. The device is intended to let laparoscopic and robotic surgical teams clear lens obstructions in-vivo and in-situ, without navigating the scope away from the surgical site or removing it from the patient for cleaning.

The product combines a micro-mechanical wiping mechanism with irrigation to address fog (condensation), blood, and particulate debris such as fat tissue and cautery residue. It is described as universally compatible with any 5 or 10 mm scope and able to pass through leading trocars, and is operated via a single-hand 360-degree trigger so it can be actuated from any orientation. The attachment is single-use, which the company positions as avoiding capital expenditure for hospitals.

The company frames the clinical problem as lens occlusion in minimally invasive surgery forcing full scope removal and repeated cleaning, which disrupts operating-room workflow, lengthens procedures, and creates patient risk. It cites recurrent visual impairment from smudged camera lenses as affecting 90% of robotic-assisted surgeries, contributing to lost procedure time, reduced control during critical moments, and surgeon decision fatigue.

Business model

Bloom Surgical's device is a single-use disposable attachment, which the company positions as requiring no capital expenditure by the buying facility, implying a per-procedure consumable purchase rather than an equipment sale.

Sales of a single-use disposable laparoscope cleaning attachment, positioned as avoiding capital expenditure for the customer.

Traction

Awarded a U.S. National Science Foundation Small Business Innovation Research Phase I grant of $256,000 in 2023 to fund research and development. The website indicates the product is in development, with an email list for updates on development progress and timing.

Latest developments

In 2023 Bloom Surgical received an NSF SBIR Phase I grant of $256,000 to prove feasibility of its wiping mechanism and in-abdomen lens cleaning technology, with the CEO citing intensifying visualization problems as robotic and automated procedures are adopted.

Full profile — market position, technology, go-to-market, geography, history

Market position

An early-stage entrant addressing intraoperative visualization in minimally invasive and robotic surgery, with a product still in development and feasibility work funded by a Phase I SBIR grant as of 2023.

The company positions its device against the standard practice of removing the laparoscope from the abdomen for cleaning: it enables rapid cleaning in-situ, combines a wiper with irrigation to address fog, blood, and cautery debris, is universally compatible with 5 and 10 mm scopes and leading trocars, offers 360-degree single-hand actuation, and is single-use so no capital purchase is required.

Technology

The core technology is a micro-mechanical wiping mechanism paired with irrigation, packaged as a disposable attachment that mounts on the laparoscope. The design is described as origami-inspired, allowing the attachment to fit any 5 or 10 mm scope and pass through leading trocars while remaining in the abdomen during cleaning. Actuation is via a single-hand 360-degree trigger. Phase I SBIR work was directed at proving technical feasibility of the wiping mechanism and in-abdomen lens cleaning approach.

Go-to-market

The company markets directly to laparoscopic surgeons through its website, which collects email sign-ups for product development and timing updates, and references affiliations and partners. It has used non-dilutive federal grant funding (NSF SBIR Phase I) to advance development, and is a participant in Utah's life sciences ecosystem, with its grant announced through the state industry association BioUtah.

Laparoscopic and robotic surgical teams — surgeons and operating-room staff performing minimally invasive abdominal procedures — and the hospitals and surgical facilities that supply them with disposables.

Geography

Headquartered in Utah, United States; the 2023 grant announcement was datelined Salt Lake City, Utah.

History

Bloom Surgical, Inc. is incorporated in Utah and led by cofounder and CEO Jacob Sheffield. In June 2023 the company announced a U.S. National Science Foundation SBIR Phase I award of $256,000 to develop its micro-mechanical wiping mechanism and in-abdomen lens cleaning solution; the award was publicized by BioUtah in July 2023. The team listed on the company site comprises a CEO and cofounder, a COO, a CTO, a chief of staff, and two R&D engineers, supported by a board and advisory board covering business operations, fundraising, clinical, product and quality, and business relations.

Compiled by commissioned research from 3 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
NSF SBIR Phase I grant amountJun 2023$256K
Share of robotic-assisted surgeries disrupted by recurrent visual impairment froJun 202390%
Team members listed on company websiteJan 20256 people

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 1

launches, deals, and filings
Jun 2023
Bloom Surgical awarded $256,000 NSF SBIR Phase I grant

Bloom Surgical, Inc. was awarded a U.S. National Science Foundation Small Business Innovation Research Phase I grant of $256,000 to conduct research and development on a micro-mechanical wiping mechanism and in-abdomen lens cleaning solution for resolving intraoperative visual disruptions in minimally invasive and robotic procedures.

$256K source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Research sources · 3

primary sources listed

3 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Bloomsurgical do?
Bloom Surgical develops a single-use, origami-inspired wiper and irrigation attachment that cleans laparoscope lenses inside the abdomen.
Who are Bloomsurgical's investors?
Bloomsurgical's investors include Utah Innovation Fund.